
Anti-inflammatory peptide supporting rapid tissue healing.
Select Size
Select Bundle
Compound
KPV
Form
Lyophilized Powder
Purity
>99%
Storage
-20°C
Science
KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal of alpha-MSH. It exhibits potent anti-inflammatory properties by inhibiting NF-kB and inflammatory cytokine pathways (IL-1, IL-6, TNF-alpha). Unlike alpha-MSH, KPV provides anti-inflammatory benefits without melanogenic effects, making it a targeted therapeutic for inflammatory conditions.
Benefits
Research
Research protocols typically use 250-500mcg daily via subcutaneous injection, or 1-2mg oral administration. Often studied in 4-8 week cycles for inflammatory conditions.
Research Comparison
| Peptide | ||
|---|---|---|
| Aliases | Lysine-Proline-Valine | |
| CAS Number | 87761-24-4 | |
| Molecular Weight | 329.44 g/mol | |
| Sequence | Lys-Pro-Val | |
| Purity | >99% (HPLC) | |
| Form | Lyophilized Powder | |
| Storage | -20°C | |
| Price | £30 | |
| Mechanism | KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal of alpha-MSH. It exhibits potent anti-inflammatory properties by inhibiting NF-kB and inflammatory cytokine pathways (IL-1, IL-6, TNF-alpha). Unlike alpha-MSH, KPV provides anti-inflammatory benefits without melanogenic effects, making it a targeted therapeutic for inflammatory conditions. | |
| Dosage Protocol | Research protocols typically use 250-500mcg daily via subcutaneous injection, or 1-2mg oral administration. Often studied in 4-8 week cycles for inflammatory conditions. |
Comparison for research purposes only · All peptides >99% HPLC-verified purity
Stability
Store lyophilized powder at -20°C. Reconstituted solution stable at 2-8°C for up to 30 days. Protect from light.
Safety
KPV has demonstrated excellent safety in preclinical studies. No significant adverse effects reported at therapeutic doses. No melanogenic or hormonal effects observed.
Scientific Literature
Journal of Immunology, 2009
Inhibits NF-kB and pro-inflammatory cytokines
PubMed →Annals of the New York Academy of Sciences, 2003
Potent anti-inflammatory without melanogenic effects
PubMed →Gut, 2014
Reduces intestinal inflammation in colitis models
PubMed →Research Tool
Calculate precise dosing with a visual syringe ruler
Select your parameters and get precise instructions with a visual syringe ruler
For a dose of 20 units pull the syringe to 20
Units to Draw
20 U
Volume
0.200 ml
Concentration
50 mcg/U
Total Doses
10
Research use only · Not for human consumption
Your cart is empty